|
Notification of cessation of securities - IMR
|
9 June 2023 at 11:55am
|
|
Appendix 3Y - SW
|
7 June 2023 at 11:40am
|
|
Notification regarding unquoted securities - IMR
|
6 June 2023 at 10:00am
|
|
Release from Voluntary Escrow
|
26 May 2023 at 11:10am
|
|
Appendix 3Y - PM
|
24 May 2023 at 12:35pm
|
|
Appendix 3Y - AM
|
24 May 2023 at 12:35pm
|
|
Appendix 3Y - MT
|
24 May 2023 at 12:35pm
|
|
Application for quotation of securities - IMR
|
24 May 2023 at 12:30pm
|
|
Results of Meeting
|
12 May 2023 at 2:40pm
|
|
Annual Stockholder Meeting Presentation Slides
|
12 May 2023 at 8:25am
|
|
Annual Meeting Of Stockholders Chair's Address
|
12 May 2023 at 8:25am
|
|
Imricor Q1 FY23 Quarterley Activities Report and Appendix 4C
|
27 April 2023 at 9:20am
|
|
Imricor's Products to Operate with GE Healthcare MRI Systems
|
24 April 2023 at 9:55am
|
|
Notification of cessation of securities - IMR
|
14 April 2023 at 11:15am
|
|
Business Update - Correction
|
13 April 2023 at 3:15pm
|
|
Business Update
|
13 April 2023 at 10:10am
|
|
Imricor Establishes First iCMR Site in Switzerland
|
11 April 2023 at 9:50am
|
|
Letter to Shareholders and Online Meeting Guide
|
6 April 2023 at 9:40am
|
|
Notice of Annual Stockholders Meeting and CDI Voting Form
|
6 April 2023 at 9:40am
|
|
Appendix 4G and Corporate Governance Statement
|
6 April 2023 at 9:35am
|
|
Annual Report to shareholders
|
6 April 2023 at 9:35am
|
|
Notification regarding unquoted securities - IMR
|
29 March 2023 at 11:20am
|
|
Cleansing Notice - Convertible Note Tranche 2
|
29 March 2023 at 10:10am
|
|
Appendix 3B - Tranche 2 Convertible Note and Warrants
|
29 March 2023 at 10:05am
|
|
Appendix 3Y - MT
|
17 March 2023 at 2:20pm
|
|
NWR Virtual Healthcare Conference
|
15 March 2023 at 11:10am
|
|
Appendix3Y - MT
|
13 March 2023 at 9:00am
|
|
Appendix 3Y - SW
|
7 March 2023 at 11:15am
|
|
Results of Meeting
|
7 March 2023 at 11:15am
|
|
FY22 Results Investor Presentation
|
23 February 2023 at 9:10am
|
|
Imricor Releases FY22 Results
|
23 February 2023 at 9:10am
|
|
Appendix 4E and FY22 Financial Accounts
|
23 February 2023 at 9:10am
|
|
Online Meeting Guide
|
15 February 2023 at 10:05am
|
|
Notice of Extraordinary General Meeting/Proxy Form
|
13 February 2023 at 2:59pm
|
|
Ceasing to be a substantial holder
|
13 February 2023 at 8:30am
|
|
FY22 Results Webinar
|
8 February 2023 at 10:25am
|
|
Change in substantial holding
|
7 February 2023 at 8:40am
|
|
Change in substantial holding
|
3 February 2023 at 8:45am
|
|
Imricor and GE HealthCare MOU for Collaboration
|
27 January 2023 at 9:15am
|
|
Imricor Receives IDE Approval from US FDA
|
24 January 2023 at 9:45am
|
|
Imricor Q4 FY22 Quarterley Activities Report and Appendix 4C
|
20 January 2023 at 9:55am
|
|
Notification of cessation of securities - IMR
|
13 January 2023 at 1:10pm
|
|
Notification regarding unquoted securities - IMR
|
3 January 2023 at 9:45am
|
|
Cleansing Notice - Convertible Note Tranche 1
|
23 December 2022 at 12:00pm
|
|
Appendix 3B - Tranche 1 Convertible Note and Warrants
|
22 December 2022 at 5:35pm
|
|
Imricor Recives North Dakota US$1.5m LIFT Loan Approval
|
22 December 2022 at 10:00am
|
|
Notification of cessation of securities - IMR
|
21 December 2022 at 10:05am
|
|
Imricor to Raise US$5 million via Convertible Note
|
19 December 2022 at 10:00am
|
|
VISABL-VT Ethics Committee Approval and NorthStar-MR Update
|
15 December 2022 at 9:30am
|
|
US$5 Million Convertible Note and Business Update
|
12 December 2022 at 10:25am
|
Imricor Medical Systems, Inc